|
|
Article: BB Medtech AG Makes $12 Million Investment In Israeli Biotech Company.
- Article from:
- Israel Business Today
- Article date:
- September 15, 1998
CopyrightCOPYRIGHT 1998 Israel Business Today. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
BB Medtech a part of Swiss Bellevue asset management group, which manages over $2 billion, made a $12 million investment in Combact Diagnostic Systems. The Israeli biotech company is developing a process to automatically detect bacteria in urine. Instead of doctors and patients having to wait days for urine tests to be returned from diagnostic laboratories, this process will enable doctors to receive almost on the spot results. This is Combact third round of financing. In this round the company has raised $14.5 million and intends to raise a total of $20 million. In Combact's pervious private placements both ...
Related newspaper, magazine, and journal articles:
|
|
Article: SALE INFUSES NEW BLOOD IN BIOTECH COMPANY SOMATOGEN ...
Rocky Mountain News (Denver, CO);
February 25, 1998 ;
700+ words
... ... 55.75, down 69 cents. A Boulder biotech company thought to be worth just $40 million ... March, de Bruin said. The small biotech company decided that any new partner would ... his Boulder office. Somatogen, a biotech company, was sold Tuesday to Baxter International ...
|
|